Condition

CLL/SLL

Treatments and trials tagged CLL/SLL. Filter by country, access level, or patient stories.

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States

Once-Daily Pill for Adults with Untreated CLL or SLL

Jaypirca (pirtobrutinib) — once-daily pill for adults with previously untreated CLL or SLL and no known 17p deletion

US label section 1.3 added 10/2026; BRUIN CLL-313 NCT05023980

This is for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have not been treated before and have no known 17p deletion.

October 18, 2026